Investing in Cancer Research


As part of Labor’s $2.3 billion Medicare Cancer Plan, we will invest $125 million in ground-breaking clinical trials and cancer research.


Labor’s Medicare Cancer Plan is the most important reform to Medicare since it was introduced by Bob Hawke.

One in two Australians will be diagnosed with cancer, which means every year 150,000 Australians will be given the news that they will have to fight cancer.

In addition to slashing out-of-pocket costs for cancer patients, Labor will invest $125 million in a fund to fight cancer – giving our world-class researchers additional resources to search for a cure, including:

  • $20 million to give around 1,800 blood cancer patients access to new and emerging treatments – working with the Leukaemia Foundation and other partners to develop the new Right to Trial program.
  • $20 million for the Avner Pancreatic Cancer Foundation to implement a comprehensive Pancreatic Cancer Medical Research Strategy.
  • $26 million in the amazing work of the Australian Clinical Trials Alliance in clinical trials to help patients access better care now and help strengthen our healthcare system into the future.

Labor will pay for our Medicare Cancer Plan by making multinationals pay their fair share and closing tax loopholes used by the top end of town.